You have 9 free searches left this month | for more free features.

Ranibizumab intravitreal injection

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Focal Laser Single Intravitreal Ranibizumab Retinal Artery

Completed
  • Retinal Artery Macroaneurysm
  • Dual focal laser and intravitreal Ranibizumab injection
  • Cairo, Egypt
    Kasr alainy faculty of medicine
Jan 29, 2023

Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))

Completed
  • Retina Disease
  • +2 more
  • Ranibizumab (0.25 mg/0.025 mL)
  • Zagazig, Egypt
    Zagazig University, Faculty of medicine
Jan 26, 2023

Diabetic Macular Edema Trial in Cairo (intra-vitreal injection of Ranibizumab, anterior chamber paracentesis)

Recruiting
  • Diabetic Macular Edema
  • intra-vitreal injection of Ranibizumab
  • anterior chamber paracentesis
  • Cairo, Egypt
    Ain shams university
May 15, 2023

Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Jul 28, 2022

Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

Recruiting
  • Mild Non-proliferative Diabetic Retinopathy
  • +2 more
  • Ranibizumab Injection [Lucentis]
  • Phacoemulsification
  • Shanghai, Shanghai, China
    Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)

Recruiting
  • Age Related Macular Degeneration
  • Nedlands, Western Australia, Australia
    Lions Eye Institute
Feb 7, 2022

Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab

Recruiting
  • Neovascular Age-related Macular Degeneration
  • SUSVIMO (ranibizumab injection)
  • LUCENTIS (ranibizumab injection)
  • Mesa, Arizona
  • +32 more
Jan 13, 2023

Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)

Completed
  • Proliferative Diabetic Retinopathy
  • preoperative group and intraoperative group
  • Beijing, Beijing, China
    People's Hospital of Peking University
Jun 1, 2022

Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,

Completed
  • Branch Retinal Vein Occlusion
  • +2 more
  • Beijing, Beijing, China
    Beijing Hospital
Dec 25, 2022

Retinopathy of Prematurity Both Eyes Trial in Zagazig (Bevacizumab, Ranibizumab)

Recruiting
  • Retinopathy of Prematurity Both Eyes
  • Bevacizumab, Ranibizumab
  • Zagazig, Egypt
    Zagazig University
Aug 26, 2021

Diabetic Retinopathy Trial in Nantong (Ranibizumab Injection [Lucentis], Inner limiting membrane stripping, Dexamethasone

Recruiting
  • Diabetic Retinopathy
  • Ranibizumab Injection [Lucentis]
  • +2 more
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 7, 2022

Intravitreal Injection Site and Perceived Pain

Recruiting
  • Pain
  • Intravitreal injection site
  • Galveston, Texas
    University of Texas Medical Branch
Jan 19, 2023

OCTA and Polypoidal Choroidal Vasculopathy

Completed
  • Polypoidal Choroidal Vasculopathy
  • Ranibizumab Injection
  • Naples, Italy
    University of Naples "Federico II"
Jan 14, 2021

Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)

Completed
  • Diabetic Macular Edema
  • Lucentis alone group
  • Lucentis dexamethasone group
  • Giza, Cairo, Egypt
    Khaled G Abueleinen
Feb 27, 2022

Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal

Recruiting
  • Pain
  • +2 more
  • Use of bromfenac 0.09% to reduce intravitreal injection pain
  • Use of artificial tears to reduce intravitreal injection pain
  • Boston, Massachusetts
  • +4 more
Nov 8, 2023

Diabetic Retinopathy, Macular Edema Trial in Cleveland (aflibercept)

Completed
  • Diabetic Retinopathy
  • Macular Edema
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
Jan 25, 2021

Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

Completed
  • Wet Age-related Macular Degeneration
  • Intravitreal anti-VEGF
  • +2 more
  • Boston, Massachusetts
  • +1 more
May 24, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

Suspended
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Intravitreal injection of IBI302(dose 1)
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 17, 2023

Long Term Outcome of Intravitreal Ranibizumab for ROP

Completed
  • Retinopathy of Prematurity
  • cycloplegic refraction
  • Mansoura, Dakahlia, Egypt
    Mansoura University
Aug 28, 2020

Uveitis, Macular Edema Trial in Worldwide (Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg,

Completed
  • Uveitis
  • Macular Edema
  • Dexamethasone intravitreal implant 0.7 mg
  • +2 more
  • Los Angeles, California
  • +32 more
Mar 31, 2022

Intravitreal Ranibizumab in Recurrent ROP

Completed
  • Retinopathy of Prematurity
  • intravitreal injection of Ranibizumab
  • Mansoura, Dakahlia, Egypt
    Mansoura University
Aug 31, 2020

Diabete Type 2, Cataract, Triamcinolone Acetonide Trial in Damascus (Triamcinolone Acetonide)

Completed
  • Diabete Type 2
  • +3 more
  • Triamcinolone Acetonide
  • Damascus, Syrian Arab Republic
    Damascus University
Oct 21, 2022

Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab

Recruiting
  • Diabetic Retinopathy
  • +3 more
  • Ranibizumab Injection
  • PPV
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 11, 2022

Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)

Completed
  • Proliferative Diabetic Retinopathy
  • preoperative intravitreal injections of ranibizumab or conbercept
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 7, 2022